These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors. Aloyo VJ; Berg KA; Spampinato U; Clarke WP; Harvey JA Pharmacol Ther; 2009 Feb; 121(2):160-73. PubMed ID: 19109993 [TBL] [Abstract][Full Text] [Related]
5. Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective. Shonberg J; Lopez L; Scammells PJ; Christopoulos A; Capuano B; Lane JR Med Res Rev; 2014 Nov; 34(6):1286-330. PubMed ID: 24796277 [TBL] [Abstract][Full Text] [Related]
6. The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors. Andressen KW; Manfra O; Brevik CH; Ulsund AH; Vanhoenacker P; Levy FO; Krobert KA Br J Pharmacol; 2015 Aug; 172(15):3846-60. PubMed ID: 25884989 [TBL] [Abstract][Full Text] [Related]
7. Inverse agonism and its therapeutic significance. Khilnani G; Khilnani AK Indian J Pharmacol; 2011 Sep; 43(5):492-501. PubMed ID: 22021988 [TBL] [Abstract][Full Text] [Related]
8. The evasive nature of drug efficacy: implications for drug discovery. Galandrin S; Oligny-Longpré G; Bouvier M Trends Pharmacol Sci; 2007 Aug; 28(8):423-30. PubMed ID: 17659355 [TBL] [Abstract][Full Text] [Related]
9. Methods to measure g-protein-coupled receptor activity for the identification of inverse agonists. Barreda-Gómez G; Teresa Giralt M; Rodríguez-Puertas R Methods Enzymol; 2010; 485():261-73. PubMed ID: 21050922 [TBL] [Abstract][Full Text] [Related]
10. Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data. Stott LA; Hall DA; Holliday ND Biochem Pharmacol; 2016 Feb; 101():1-12. PubMed ID: 26478533 [TBL] [Abstract][Full Text] [Related]
11. Analysis of functional selectivity through G protein-dependent and -independent signaling pathways at the adrenergic α(2C) receptor. Kurko D; Kapui Z; Nagy J; Lendvai B; Kolok S Brain Res Bull; 2014 Aug; 107():89-101. PubMed ID: 25080296 [TBL] [Abstract][Full Text] [Related]
12. Constitutive activity in melanocortin-4 receptor: biased signaling of inverse agonists. Tao YX Adv Pharmacol; 2014; 70():135-54. PubMed ID: 24931195 [TBL] [Abstract][Full Text] [Related]